Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original ANDA for memantine hydrochloride from Aurobindo Pharma Limited, a generic version of memantine used to treat Alzhe…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved the original application for memantine hydrochloride tablets from Macleods Pharmaceuticals Limited, a generic version indic…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved the original application for a generic memantine hydrochloride product from Unichem Pharmaceuticals (USA), Inc. for the tre…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved an original ANDA for memantine hydrochloride from Macleods Pharmaceuticals Limited. The drug is used to treat Alzheimer's disea…
-
FDA approval · 2015-10-13FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Chartwell Governmental & Specialty RX, LLC.)
The FDA approved memantine hydrochloride under an original ANDA filed by Chartwell Governmental & Specialty RX, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-10-06FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for NAMZARIC (memantine hydrochloride and donepezil hydrochloride) from Allergan, Inc.
-
FDA approval · 2015-09-01FDA Approved: NAMZARIC — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Namzaric (memantine hydrochloride and donepezil hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2015-08-31FDA Approved: GALANTAMINE HYDROBROMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for galantamine hydrobromide from Sun Pharmaceutical Industries, likely to update labeling or re…
-
FDA approval · 2015-07-31FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves the original application for memantine hydrochloride (Upsher-Smith Laboratories) as a generic treatment for Alzheimer's disease…
-
FDA approval · 2015-07-22FDA Approved: RIVASTIGMINE TARTRATE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA granted supplemental approval for a generic rivastigmine tartrate product from Dr. Reddy's Laboratories Limited (ANDA 077130).
-
FDA approval · 2015-07-20FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) submitted by Eisai Inc.
-
FDA approval · 2015-07-20FDA Approved: ARICEPT — Supplemental Application (Eisai Inc.)
FDA approved a supplemental application for ARICEPT (donepezil hydrochloride) from Eisai Inc.
-
FDA approval · 2015-07-20FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Dr. Reddys Laboratories Limited)
FDA approves a supplemental application for donepezil hydrochloride from Dr. Reddys Laboratories Limited. Donepezil is a treatment for Alzhe…
-
FDA approval · 2015-07-20FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride from Torrent Pharmaceuticals Limited, authorizing changes to its labelin…
-
FDA approval · 2015-07-09FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for AMYVID (Florbetapir F-18) by Eli Lilly and Company.
-
FDA approval · 2015-06-25FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for AMYVID (Florbetapir F 18) from Eli Lilly and Company.
-
FDA approval · 2015-06-24FDA Approved: RIVASTIGMINE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for rivastigmine submitted by Sandoz Inc, indicating an approved change related to this drug. The ac…
-
FDA approval · 2015-06-23FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute)
FDA approved the original application for Fludeoxyglucose F-18 as a radiopharmaceutical imaging agent for PET scans, developed by the Univer…
-
FDA approval · 2015-06-05FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's original generic application for donepezil hydrochloride, making a generic version of the Alzheimer's …
-
FDA approval · 2015-05-19FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
FDA approved a supplemental application for NEURACEQ (florbetaben F-18) from Lantheus Biosciences Ltd., updating labeling to support its use…
-
FDA approval · 2015-05-18FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (FLORBETABEN F 18) submitted by Lantheus Biosciences Ltd.
-
FDA approval · 2015-05-01FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for donepezil hydrochloride by Torrent Pharmaceuticals Limited.
-
FDA approval · 2015-05-01FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (Biomedical Research Foundation of Northwest Louisiana)
FDA approved Fluorodeoxyglucose F-18 as a diagnostic radiopharmaceutical for positron emission tomography (PET) imaging under an original ap…
-
FDA approval · 2015-04-23FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic donepezil hydrochloride product from Macleods Pharmaceuticals Limited.
-
FDA approval · 2015-04-10FDA Approved: MEMANTINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved the original ANDA for memantine hydrochloride as a generic product.